Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases
Recent advances in cell based therapies for lung diseases and critical illnesses offer significant promise. Despite encouraging preclinical results, the translation of efficacy to the clinical settings have not been successful. One of the possible reasons for this is the lack of understanding of the...
Main Authors: | Sara Rolandsson Enes, Anna D. Krasnodembskaya, Karen English, Claudia C. Dos Santos, Daniel J. Weiss |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.647652/full |
Similar Items
-
Mesenchymal stem cell‐derived extracellular vesicles for the treatment of acute respiratory distress syndrome
by: Aswin Abraham, et al.
Published: (2020-01-01) -
Proteomic Profiling of the Human Fetal Multipotent Mesenchymal Stromal Cells Secretome
by: Arseniy A. Lobov, et al.
Published: (2020-11-01) -
Mesenchymal Stromal Cells
by: Stanisław Szala, et al.
Published: (2014-11-01) -
Evaluation of transport conditions for autologous bone marrow-derived mesenchymal stromal cells for therapeutic application in horses
by: Miguel Espina, et al.
Published: (2016-03-01) -
Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment
by: Dragan Primorac, et al.
Published: (2021-09-01)